Center For Financial Planning, Inc. Editas Medicine, Inc. Transaction History
Center For Financial Planning, Inc.
- $781 Million
- Q1 2025
A detailed history of Center For Financial Planning, Inc. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Center For Financial Planning, Inc. holds 50 shares of EDIT stock, worth $129. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 50
-0.0%
Holding current value
$129
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding EDIT
# of Institutions
223Shares Held
48.5MCall Options Held
436KPut Options Held
324K-
Black Rock Inc. New York, NY7.78MShares$20.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.47MShares$19.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.66MShares$6.89 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL2.6MShares$6.73 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.94MShares$5.03 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $178M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...